Stay updated on Pembrolizumab for Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic TNBC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 with no visible changes to the Study Details page.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.4.2. Removed older notices including Revision: v3.4.1 and the government funding status banner.SummaryDifference0.4%

- Check61 days agoChange DetectedA government funding-status notice is now displayed on the page, and the page revision updated from v3.4.0 to v3.4.1, replacing the previous revision.SummaryDifference0.4%

- Check68 days agoChange DetectedGlossary visibility was added to the page, and a 'Last Update Submitted that Met QC Criteria' label is now displayed. The 'No FEAR Act Data' label is present and the revision version has been updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed; this appears to be a small platform update with no changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.